Lupin Ltd Company Profile

What is the competitive landscape for LUPIN LTD, and what generic alternatives to LUPIN LTD drugs are available?

LUPIN LTD has one hundred and fifty-four approved drugs.

There is one US patent protecting LUPIN LTD drugs.

There are two patent family members on LUPIN LTD drugs in two countries and three hundred and fifty-eight supplementary protection certificates in sixteen countries.

Summary for Lupin Ltd

International Patents:	2
US Patents:	1
Tradenames:	130
Ingredients:	114
NDAs:	154
Drug Master File Entries:	194
Patent Litigation for Lupin Ltd:	See patent lawsuits for Lupin Ltd
PTAB Cases with Lupin Ltd as petitioner:	See PTAB cases with Lupin Ltd as petitioner

Drugs and US Patents for Lupin Ltd

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lupin Ltd	KURVELO	ethinyl estradiol; levonorgestrel	TABLET;ORAL-28	091408-001	Oct 17, 2012	AB	RX	No	No
Lupin Ltd	REPAGLINIDE AND METFORMIN HYDROCHLORIDE	metformin hydrochloride; repaglinide	TABLET;ORAL	200624-002	Jul 15, 2015		DISCN	No	No
Lupin Ltd	IMIPRAMINE PAMOATE	imipramine pamoate	CAPSULE;ORAL	090444-002	Apr 16, 2010	AB	RX	No	No
Lupin Ltd	TELMISARTAN AND AMLODIPINE	amlodipine besylate; telmisartan	TABLET;ORAL	201586-004	Jan 8, 2014	AB	RX	No	No
Lupin Ltd	JENCYCLA	norethindrone	TABLET;ORAL-28	091323-001	Mar 28, 2013	AB2	RX	No	No
Lupin Ltd	LAMIVUDINE AND ZIDOVUDINE	lamivudine; zidovudine	TABLET;ORAL	090246-001	May 15, 2012	AB	RX	No	No
Lupin Ltd	CELECOXIB	celecoxib	CAPSULE;ORAL	202240-004	Jun 9, 2015	AB	RX	No	No

Paragraph IV (Patent) Challenges for LUPIN LTD drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	for Oral Suspension	500 mg/5 mL		2014-07-22
	Delayed-release Tablets	20 mg		2015-06-03

International Patents for Lupin Ltd Drugs

Country	Patent Number	Estimated Expiration
Germany	112007000920
World Intellectual Property Organization (WIPO)	2007119249

Supplementary Protection Certificates for Lupin Ltd Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0720599	300689	Netherlands		PRODUCT NAME: EZETIMIBE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, EN ATORVASTATINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER ATORVASTATINE CALCIUM TRIHYDRATE; NATIONAL REGISTRATION NO/DATE: RVG114373-114376 20141027; FIRST REGISTRATION: FR 2014091200122 20140912
1453521	300814	Netherlands		PRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211
0392059	SPC/GB02/046	United Kingdom		PRODUCT NAME: MEMANTINE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS; REGISTERED: UK EU/1/02/219/001 20020515; UK EU/1/02/219/002 20020515; UK EU/1/02/219/003 20020515; UK EU/1/02/219/004 20020515; UK EU/1/02/219/005 20020515; UK EU/1/02/219/006 20020515
1214076	SZ 49/2008	Austria		PRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON
0720599	122014000088	Germany		PRODUCT NAME: EZETIMIB ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON IN KOMBINATION MIT ATORVASTATIN ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON, INSBESONDERE ATORVASTATIN ALS ATORVASTATINCALCIUMTRIHYDRAT; NAT. REGISTRATION NO/DATE: 90223.00.00 20141113; FIRST REGISTRATION: FRANKREICH CIS: 6 928 917 6 20140912
0480717	98C0025	Belgium		PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215
0473687	99C0008	Belgium		PRODUCT NAME: FOSPHENYTOINUM DINATRICUM; REGISTRATION NO/DATE: 19 IS 102 F12 19980901; FIRST REGISTRATION: GB PL00019/1057 19980204

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Lupin
• Lupin Atlantis
• Lupin Ltd
• Lupin Pharms